Infective endocarditis, staphylococci, streptococci
Introduction
To determine the clinical features and long term prognosis of infective endocarditis in patients who were not intravenous drugs abusers.
Methods
• Prospective series with 138 consecutive cases of infective endocarditis diagnosed and treated from January 1987 to March 1997
• Early prosthetic valve endocarditis (PVE) was diagnosed when infection occurred in the first two months following heart surgery, while intermediate and late PVE were diagnosed when infection developed at 2-12 months and more than one year, respectively
• All patients received antibiotic treatment for 4-6 weeks
• Surgery was indicated in the following circumstances: moderate to severe heart failure, significant valve regurgitation, repeated major emboli, severe mechanical complications, in cases of early PVE, endocarditis on pacemaker leads, and in cases of persistent sepsis
• Emergency surgery was that which could not be postponed for more than 24 h. Elective surgery could be delayed for longer time periods without risk to the patient
• All survivors at the in-hospital phase were included in the prospective follow up
• Death occurring during the six weeks post-diagnosis was considered early mortality
Results
Infective endocarditis was diagnosed in 124 out of 138 cases. Native valve endocarditis (NVE) accounted for 69% of the cases and PVE 31%. A presumed portal of entry was identified for 38% of the cases. Staphylococcus was the organism most frequently responsible for NVE cases, while streptococcal infection was the most common in the PVE cases. Echocardiography detected vegetations in 86% of the cases (59% with transthoracic echocardiography and 92% with transoesophageal echocardiography [P < 0.01]) and this difference was greater in the PVE group than in the NVE group. Cardiac and extracardiac complications were a frequent finding (83%). Surgery was carried out in the active phase in 50% of the cases with NVE and 53% of the cases with PVE. Elective surgery predominated over emergency procedures (29% vs 22%). The highest mortality rate (50%) was registered among early PVE. Prognosis was not affected by the type of infective endocarditis (NVE or PVE) or by the site and causal agent. Overall survival was 75% at 1 year and 71% at 5 and 10 years (overall survival for NVE was 78% at 1 year and 76% at 5 years, and for PVE it was 67% and 59%, respectively [P < 0.01]). Follow-up event free survival at 1 year was 92%, and 82% at 5 and 10 years. One and 5 year survival rates for survivors past active phase were 98% and 96% for cases of NVE, while in cases of PVE they were 90% and 82%, respectively (P < 0.05) .
